ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,457,127 | -28.6% | 1,917,105 | +0.5% | 0.01% | -20.0% |
| Q2 2023 | $53,837,205 | -6.9% | 1,908,444 | -43.2% | 0.01% | -9.1% |
| Q1 2023 | $57,797,659 | -20.7% | 3,360,329 | -7.1% | 0.01% | -26.7% |
| Q4 2022 | $72,876,448 | +7.8% | 3,618,493 | +15.9% | 0.02% | +7.1% |
| Q3 2022 | $67,630,000 | +73.8% | 3,122,364 | +125.5% | 0.01% | +75.0% |
| Q2 2022 | $38,911,000 | +189.4% | 1,384,704 | +375.1% | 0.01% | +300.0% |
| Q1 2022 | $13,447,000 | +4.9% | 291,459 | +91.2% | 0.00% | 0.0% |
| Q4 2021 | $12,815,000 | +42.9% | 152,445 | +13.2% | 0.00% | 0.0% |
| Q3 2021 | $8,970,000 | +91.1% | 134,611 | +52.6% | 0.00% | +100.0% |
| Q2 2021 | $4,693,000 | – | 88,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 2,099,583 | $42,117,635 | 14.06% |
| Mayo Clinic | 187,143 | $3,754,089 | 7.23% |
| Matrix Capital Management Company, LP | 13,959,973 | $280,037,058 | 3.36% |
| 5AM Venture Management, LLC | 490,000 | $9,829,400 | 2.83% |
| Eventide Asset Management | 7,814,039 | $156,749,622 | 2.82% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $19,287,410 | 2.70% |
| Avidity Partners Management LP | 2,100,000 | $42,126,000 | 1.70% |
| First Light Asset Management, LLC | 848,477 | $17,020,449 | 1.62% |
| Sofinnova Investments, Inc. | 1,211,641 | $24,305,518 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 386,525 | $7,753,692 | 1.51% |